top of page

Exclusive: Pfizer’s CEO on Q2 earnings

Albert Bourla discusses Q2 earnings, FTC and Seagen, Pfizer’s capacity for more deals, GLP-1s, and provides an update on the NC tornado damage.



Comentarios


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page